Approved Study Database

Ref. No. Scientific Title Principal investigator
2022.426 Effect of a Novel Herbal Patch for the Treatment of Plantar Fasciitis – A Single-blind Randomized Controlled Trial Prof. LUI Pauline Po Yee
呂寶儀
2025.214 Investigating the Prevalence of Tendinopathy and Tendon Injuries in Patients with Metabolic Syndrome: The Impact of Metabolic Drugs Prof. LUI Pauline Po Yee
2025.363 Epidemiological analytics in the realm of big data for the enhancement of the understanding of orthopaedic conditions Prof. LUI Pauline Po Yee
2025.882 Application of exosomes-derived from tendon-derived stem cells loaded in gelatin methacrylate as an injectable biomaterial therapy for treating patients with Achilles tendinopathy: a first-in-human clinical trial Prof. Lui Pauline Po Yee
2024.105 Development of a Biobank for Studying the Pathogenesis and Treatment of Musculoskeletal Disorders Prof. LUI Pauline Po Yee
呂寶儀
2024.130 Effect of Pulsed Electromagnetic Fields on Promoting Hamstring Muscle Strength after Anterior Cruciate Ligament Reconstruction with Hamstring Autograft: A Double-Blind, Placebo-Controlled, Randomised Clinical Trial Prof. LUI Pauline Po Yee
2024.012 Comparison of Functioning Among Dementia Patients with and without Getting Lost Miss LUI Pui Yin
2019.507 Helicobacter pylori, Atrophic Gastritis and Intestinal Metaplasia Registry Dr. LUI Rashid
2020.588 Guangzhou-Oxford-Taipei-HongKong International Collaborative Sessile Serrated Lesion Study Dr. LUI Rashid
2022.033 Clinico-genomic predictors of outcomes among patients with HIV and cancer Dr. LUI Rashid
2021.217 coMpliAnce with evideNce-based cliniCal guidelines in the managemenT of acute biliaRy pancreAtitis (MANCTRA-1). Dr. LUI Rashid
2021.145 Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region Dr. LUI Rashid
2025.696 Hereditary and familial cancers including early-onset neoplasms registry Dr. LUI Rashid N.
2019.304 Single Arm, Open-label Trial on the Efficacy of Pantoprazole, Amoxicillin and Clarithromycin Triple Therapy for 14 Days as First-line Therapy for Helicobacter pylori in Hong Kong and Outcomes of Targeted Screening for Household Members Dr. LUI Rashid N.
雷諾信
2023.490 International Liver cAncer Database (ILIAD) Consortium Study Dr. LUI Rashid N.S.
2023.465 Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial Dr. LUI Rashid N.S.
2022.371 Multicentre assessment of liver frailty using the Liver frailty index in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolisation (TACE) or systemic therapy Dr. LUI Rashid N.S.
2025.878 Cross Sectional Study on the Prevalence of Pituitary Adenomas in Lynch Syndrome Dr. Lui Rashid N.S.
2025.301 Multicentre retrospective comparative study of early-onset colorectal cancer (EOCRC): Analysis of clinicopathological, familial and prognostic differences according to the geographical location Dr. LUI Rashid N.S.
2025.312 The impact of contemporary neoadjuvant and adjuvant chemotherapy treatment regimens on recurrence and survival in resectable, borderline resectable, locally advanced and metastatic adenocarcinoma arising from IPMN and internal validation of 2023 KYOTO Guidelines: ADENO-IPMN 2 study Dr. LUI Rashid N.S.
2021.033 Randomized Controlled Trial of Aspirin for the Prevention of Recurrence in Liver Cancer Dr. LUI Rashid Nok Shun
雷諾信
2022.323 Effectiveness of the Current Use of Hospital Authority (HA) Mobile Application HA Go in Exercise Program for Knee Osteoarthritis (OA) in Local Elderly Patients Ms. LUI Sweetie R.
雷蕢珊
2009.282 Socio-demographic Risk Factors for adolescent Sports Injury in Hong Kong: A Pilot Study Ms. Lui Tai Wah
2025.139 Epidemiology of fusariosis in NTEC Dr. LUI Tin Long
2011.282 EFFECTIVENESS OF TOE SPREADER & DYNAMIC HALLUX VALGUS STRAP ON FOOT FUNCTION FOR JUVENILE HALLUX VALGUS - PROSPECTIVE, CROSSOVER RANDOMIZED CONTROL TRIAL Dr. Lui Tun Hing
2009.369 Determinants and barriers for help seeking in persons with self-harm and aggressive ideations Dr. Lui Victor Wing Cheong
2010.081 Oncogenic Regulation of TIGAR by STAT3: A Mechanistic Study Ph.D. LUI Vivian Wai Yan
2017.145 RAC1 Genomic Alterations Drive Head and Neck Cancer Progression Dr. LUI Vivian Wai Yan
呂偉欣
2017.293 ALK/PIK3CA Genetic Coupling: Implications for Progression and Personalized Therapy in Head and Neck Cancer Dr. LUI Vivian Wai Yan
呂偉欣
2011.612 Comparison of satisfaction with communication during general outpatient consultation of doctors and patients Ms Lui Wai Yan
2008.195 High-Content Screening (HCS) Platform for Molecular Drug Testing, Therapeutic Target Identification and Mechanistic Signaling Studies in Asian Prevalent Cancers Ph.D., Assistant Professor LUI Wai Yan Vivian
2008.196 Biological Implication of Elefated Serum Hepatocyte Growth Factor (HGF) in the Progressionof Nasopharyngeal Carcinoma (NPC) Ph.D., Assistant Professor LUI Wai Yan Vivian
2008.022 Oncogenic Dependency on Receptor Tyrosine Kinase (RTK): Implication for Molecular Targeting in Nasopharyngeal Carcinoma (NPC) Ph.D., Assistant Professor LUI Wai Yan Vivian
2008.365 Validation Study of Assessment of Capacity for Everday Decision-Making for Chinese Elderly Dr Lui Wing Cheong
2014.016 Surgical Outcome of Medial Rectus Resection for Recurrent Exotropia Dr. LUK Abbie
2015.487 Retinopathy of Prematurity: Applicability and Compliance of Screening Guidelines in Hong Kong Dr. LUK Abbie Sheung Wan
2014.441 A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) Dr. LUK Andrea
2014.426 A STUDY TO EVALUATE THE EFFECT OF BTI320 (SUGARDOWN®) ON POST-PRANDIAL HYPERGLYCAEMIA IN HIGH RISK CHINESE SUBJECTS WITH PRE-DIABETES Dr. LUK Andrea On Yan
2017.298 Incidence of diabetes and diabetes-related complications in Hong Kong Dr. LUK Andrea On Yan
2017.436 Single - Dose, Randomized, Open-Label, Two-Way Crossover Study to Evaluate the Bioequivalence of Azilsartan Tablets in Chinese Healthy Volunteers Dr. LUK Andrea On Yan
陸安欣
2016.046 Interactive effects of testosterone, estradiol and CAG repeat polymorphism of androgen receptor gene on cardiovascular-renal diseases and mortality in men with type 2 diabetes Dr. LUK Andrea On Yan
陸安欣
2014.056 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 26-WEEK MULTICENTER STUDY WITH A 78-WEEK EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY Dr. LUK Andrea On Yan
2017.167 Single-center, randomized, double-blind, placebo-controlled, single-dose and multiple-dose, parallel-group study to investigate pharmacokinetics, pharmacodynamics, safety and tolerability of vericiguat in Chinese healthy male subjects under fed condition Dr. LUK Andrea On Yan
陸安欣
2017.248 A different level of single-dose and multiple-dose study to evaluate the pharmacokinetics of ranolazine in a Chinese population Dr. LUK Andrea On Yan
陸安欣
2017.451 A RANDOMIZED, SPONSOR-OPEN, INVESTIGATOR-BLINDED, SUBJECT-BLINDED, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO7020531 AND METABOLITES FOLLOWING ORAL ADMINISTRATION TO CHINESE HEALTHY VOLUNTEERS Dr. LUK Andrea On Yan
陸安欣
2015.208 Using C-peptide, anti-glutamic acid decarboxylase antibodies and body mass index to identify patients with young-onset type 2 diabetes for early insulin therapy Dr. LUK Andrea On Yan
2014.699 Dose-response study of gevokizumab (S 78989 3mg, 10mg, 30mg or 60mg in patients with type 2 diabetes and diabetic kidney disease (DKD). A 66-week, international, multicenter, randomized, double-blind, parallel-group, placebo controlled, study. Dr. LUK Andrea On Yan
2016.264 Single center, randomized, open labeled pharmacokinetics study of Azilsartan Tablets in Chinese healthy volunteers Dr. LUK Andrea On Yan
2015.540 A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease Prof. LUK Andrea On Yan
陸安欣
2016.261 Establishment of a registry on young-onset diabetes in Asia Dr. LUK Andrea On Yan
陸安欣

Page 174 of 289.